All In MedTech

Device Trial Radar · NCT06511167

Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

National, Prospective, Multicentre Post Market Surveillance Study on "Patient Reported Outcome" of Implant Based Primary or Secondary Reconstructive Breast Surgery After Mastectomy Using the Complete Resorbable Synthetic TIGR® Matrix

Last checked: Nov 20, 2026Latest source record: May 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

135

Planned (sponsor's estimate)

Start

Nov 8, 2024

Primary completion

Jan 2029

Study completion Jan 2029

Sponsor

Lead sponsor
AWOgynAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Esculape GmbH
First posted
Jul 19, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational study is to evaluate the quality of life of participants who have undergone implant-based breast surgery. This will be done using the BREAST-Q questionnaire. The study also aims to demonstrate that the fully resorbable TIGR® Matrix is safe and effective.

Conditions

  • Implant Based Breast Reconstruction

Interventions

  • TIGR® MatrixDevice

    bioresorbable, synthetic, surgical mesh

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quality of Life 12 months after surgery (BREAST-Q)Time frame: 12 months after surgery

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH

    Halle, Germany · Recruiting

  • GRN-Klinik Weinheim

    Weinheim, Baden-Wurttemberg, Germany · Active not recruiting

  • Klinik und Poliklinik für Frauenheilkunde Technische Universität München

    München, Bavaria, Germany · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.